Bonesupport Holding AB (publ) (BOEUF)
USD 32.55
(-2.11%)
USD 32.55
(-2.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 688.81 Million SEK | 85.26% |
| 2022 | 371.81 Million SEK | 8.11% |
| 2021 | 343.91 Million SEK | -26.07% |
| 2020 | 465.21 Million SEK | 136.95% |
| 2019 | 196.33 Million SEK | -39.8% |
| 2018 | 326.14 Million SEK | -45.34% |
| 2017 | 596.68 Million SEK | 216.03% |
| 2016 | 188.8 Million SEK | 69.13% |
| 2015 | 111.63 Million SEK | 144.7% |
| 2014 | 45.62 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 778.65 Million SEK | 3.46% |
| 2024 Q1 | 732.89 Million SEK | 6.4% |
| 2024 Q2 | 752.61 Million SEK | 2.69% |
| 2023 Q3 | 630.95 Million SEK | 67.73% |
| 2023 Q1 | 376.47 Million SEK | 1.25% |
| 2023 Q2 | 376.18 Million SEK | -0.08% |
| 2023 FY | 688.81 Million SEK | 85.26% |
| 2023 Q4 | 688.81 Million SEK | 9.17% |
| 2022 Q1 | 332.01 Million SEK | -3.46% |
| 2022 Q3 | 369.7 Million SEK | 16.6% |
| 2022 FY | 371.81 Million SEK | 8.11% |
| 2022 Q4 | 371.81 Million SEK | 0.57% |
| 2022 Q2 | 317.06 Million SEK | -4.5% |
| 2021 Q3 | 342.67 Million SEK | -18.21% |
| 2021 FY | 343.91 Million SEK | -26.07% |
| 2021 Q2 | 418.99 Million SEK | -5.63% |
| 2021 Q4 | 343.91 Million SEK | 0.36% |
| 2021 Q1 | 444 Million SEK | -4.56% |
| 2020 Q3 | 483.45 Million SEK | -2.56% |
| 2020 Q4 | 465.21 Million SEK | -3.77% |
| 2020 Q1 | 169.5 Million SEK | -13.66% |
| 2020 FY | 465.21 Million SEK | 136.95% |
| 2020 Q2 | 496.15 Million SEK | 192.71% |
| 2019 Q4 | 196.33 Million SEK | -14.52% |
| 2019 FY | 196.33 Million SEK | -39.8% |
| 2019 Q3 | 229.68 Million SEK | -12.57% |
| 2019 Q2 | 262.71 Million SEK | -13.42% |
| 2019 Q1 | 303.43 Million SEK | -6.96% |
| 2018 Q1 | 462.71 Million SEK | -22.45% |
| 2018 Q2 | 423.61 Million SEK | -8.45% |
| 2018 Q3 | 369.36 Million SEK | -12.81% |
| 2018 Q4 | 326.14 Million SEK | -11.7% |
| 2018 FY | 326.14 Million SEK | -45.34% |
| 2017 FY | 596.68 Million SEK | 216.03% |
| 2017 Q1 | 157.18 Million SEK | -16.75% |
| 2017 Q2 | 613.77 Million SEK | 290.48% |
| 2017 Q3 | 637.67 Million SEK | 3.89% |
| 2017 Q4 | 596.68 Million SEK | -6.43% |
| 2016 FY | 188.8 Million SEK | 69.13% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | 188.8 Million SEK | 0.0% |
| 2015 FY | 111.63 Million SEK | 144.7% |
| 2014 FY | 45.62 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -37375.164% |
| Ansell Limited | 3.23 Billion USD | 78.717% |
| Ansell Limited | 3.24 Billion USD | 78.757% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -40.865% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -229228.61% |
| Psykey, Inc. | 1.72 Million USD | -39776.806% |
| ConvaTec Group Plc | 3.7 Billion USD | 81.426% |
| ConvaTec Group Plc | 3.71 Billion USD | 81.452% |
| Encision Inc. | 3.81 Million USD | -17975.763% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -105565.911% |
| LifePoint, Inc. | 8.8 Million USD | -7719.306% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -4216.972% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -76862.682% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -12448.927% |
| Reflect Scientific, Inc. | 2.66 Million USD | -25708.956% |
| SmileDirectClub, Inc. | 597.06 Million USD | -15.367% |
| Sector 10, Inc. | 1000.00 USD | -68881500.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 85.487% |
| SheerVision, Inc. | 837.56 Thousand USD | -82140.304% |
| United Health Products, Inc. | 284.64 Thousand USD | -241892.953% |
| Vasamed, Inc. | 1.6 Million USD | -42944.463% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -308546.655% |
| Yubo International Biotech Limited | 2.34 Million USD | -29229.404% |